Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Feb;4(1):82–85. doi: 10.1111/j.1365-2125.1977.tb00673.x

Altered plasma albumin in the newborn infant.

S Wallace
PMCID: PMC1428993  PMID: 402927

Full text

PDF
82

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böhme H. J., Kopperschläger G., Schulz J., Hofmann E. Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A. J Chromatogr. 1972 Jun 28;69(1):209–214. doi: 10.1016/s0021-9673(00)83103-9. [DOI] [PubMed] [Google Scholar]
  2. Chignell C. F., Vesell E. S., Starkweather D. K., Berlin C. M. The binding of sulfaphenazole to fetal, neonatal, and adult human plasma albumin. Clin Pharmacol Ther. 1971 Nov-Dec;12(6):897–901. doi: 10.1002/cpt1971126897. [DOI] [PubMed] [Google Scholar]
  3. Denko C. W., Purser D. B., Johnson R. M. Amino acid composition of serum albumin in normal individuals and in patients with rheumatoid arthritis. Clin Chem. 1970 Jan;16(1):54–57. [PubMed] [Google Scholar]
  4. Ehrnebo M., Agurell S., Jalling B., Boréus L. O. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. Eur J Clin Pharmacol. 1971 Sep;3(4):189–193. doi: 10.1007/BF00565004. [DOI] [PubMed] [Google Scholar]
  5. Ganshorn A., Kurz H. Unterschiede zwischen der Proteinbindung Neugeborener und Erwachsener und ihre Bedeutung für die pharmakologische Wirkung. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;260(2):117–118. [PubMed] [Google Scholar]
  6. Gorodischer R., Krasner J., Yaffe S. J. Serum protein binding of digoxin in newborn infants. Res Commun Chem Pathol Pharmacol. 1974 Oct;9(2):387–390. [PubMed] [Google Scholar]
  7. Krasner J., Giacoia G. P., Yaffe S. J. Drug-protein binding in the newborn infant. Ann N Y Acad Sci. 1973 Nov 26;226:101–114. doi: 10.1111/j.1749-6632.1973.tb20473.x. [DOI] [PubMed] [Google Scholar]
  8. Pruitt A. W., Dayton P. G. A comparison of the binding of drugs to adult and cord plasma. Eur J Clin Pharmacol. 1971 Dec;4(1):59–62. doi: 10.1007/BF00568901. [DOI] [PubMed] [Google Scholar]
  9. Rane A., Lunde P. K., Jalling B., Yaffe S. J., Sjöqvist F. Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants. J Pediatr. 1971 May;78(5):877–882. doi: 10.1016/s0022-3476(71)80369-4. [DOI] [PubMed] [Google Scholar]
  10. Shoeman D. W., Azarnoff D. L. The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin. Pharmacology. 1972;7(3):169–177. doi: 10.1159/000136286. [DOI] [PubMed] [Google Scholar]
  11. Travis J., Pannell R. Selective removal of albumin from plasma by affinity chromatography. Clin Chim Acta. 1973 Nov 23;49(1):49–52. doi: 10.1016/0009-8981(73)90341-0. [DOI] [PubMed] [Google Scholar]
  12. Wallace S. Factors affecting drug-protein binding in the plasma of newborn infants. Br J Clin Pharmacol. 1976 Jun;3(3):510–512. doi: 10.1111/j.1365-2125.1976.tb00630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Windorfer A., Kuenzer W., Urbanek R. The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding. Eur J Clin Pharmacol. 1974;7(3):227–231. doi: 10.1007/BF00560385. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES